Evidence map›Paper›PMID 29424692›Full record

ArticleeLife2018

LRRTM1 underlies synaptic convergence in visual thalamus.

Aboozar Monavarfeshani, Gail Stanton, Jonathan Van Name, Kaiwen Su, William A Mills, Kenya Swilling, Alicia Kerr, Natalie A Huebschman, Jianmin Su, Michael A Fox

Open access · goldAbstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Mapping the Retina onto the Brain.Cold Spring Harbor perspectives in biology · 2024
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Cre driver mouse lines for thalamocortical circuit mapping.The Journal of comparative neurology · 2022
    Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. A cell-ECM mechanism for connecting the ipsilateral eye to the brain.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Aboozar MonavarfeshaniDevelopmental and Translational Neurobiology Center, Virginia Tech Carilion Research Institute, Roanoke, United States.ORCID http://orcid.org/0000-0001-8906-5115
Gail StantonDevelopmental and Translational Neurobiology Center, Virginia Tech Carilion Research Institute, Roanoke, United States.
Jonathan Van NameDevelopmental and Translational Neurobiology Center, Virginia Tech Carilion Research Institute, Roanoke, United States.
Kaiwen SuDevelopmental and Translational Neurobiology Center, Virginia Tech Carilion Research Institute, Roanoke, United States.
William A MillsDevelopmental and Translational Neurobiology Center, Virginia Tech Carilion Research Institute, Roanoke, United States.
Kenya SwillingDevelopmental and Translational Neurobiology Center, Virginia Tech Carilion Research Institute, Roanoke, United States.
Alicia KerrDevelopmental and Translational Neurobiology Center, Virginia Tech Carilion Research Institute, Roanoke, United States.
Natalie A HuebschmanRoanoke Valley Governor School, Roanoke, United States.
Jianmin SuDevelopmental and Translational Neurobiology Center, Virginia Tech Carilion Research Institute, Roanoke, United States.
Michael A FoxDevelopmental and Translational Neurobiology Center, Virginia Tech Carilion Research Institute, Roanoke, United States.ORCID http://orcid.org/0000-0002-1649-7782
Carilion Clinic · US

Funding

Regulation of nuclei-specific retinogeniculate targetingR01EY021222 · NEI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI FOX, MICHAEL A · 2011 to 2021
$3.8M
Investigating the Mechanism of Optic Nerve Hypoplasia Associated with CASK MutationR01EY024712 · NEI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI MUKHERJEE, KONARK · 2015 to 2019
$2.0M
Virginia Tech Carilion Research Institute Translational Neurobiology Summer Undergraduate Research Fellowship (VTCRI neuroSURF)R25NS105141 · NINDS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI FOX, MICHAEL A · 2018 to 2022
$540k
NEI NIH HHS EY021222NEI NIH HHS EY024712NEI NIH HHS R01 EY021222NEI NIH HHS R01 EY024712NINDS NIH HHS R25 NS105141
6 · The paper itself

Abstract

It has long been thought that the mammalian visual system is organized into parallel pathways, with incoming visual signals being parsed in the retina based on feature (e.g. color, contrast and motion) and then transmitted to the brain in unmixed, feature-specific channels. To faithfully convey feature-specific information from retina to cortex, thalamic relay cells must receive inputs from only a small number of functionally similar retinal ganglion cells. However, recent studies challenged this by revealing substantial levels of retinal convergence onto relay cells. Here, we sought to identify mechanisms responsible for the assembly of such convergence. Using an unbiased transcriptomics approach and targeted mutant mice, we discovered a critical role for the synaptic adhesion molecule Leucine Rich Repeat Transmembrane Neuronal 1 (LRRTM1) in the emergence of retinothalamic convergence. Importantly, LRRTM1 mutant mice display impairment in visual behaviors, suggesting a functional role of retinothalamic convergence in vision.

Indexed as

AnimalsGene Expression ProfilingMembrane ProteinsMiceNerve Tissue ProteinsNeural Cell Adhesion MoleculesRetinaRetinal Ganglion CellsThalamusVisual PathwaysLRRTM1 protein, mouseMembrane ProteinsNerve Tissue ProteinsNeural Cell Adhesion Moleculesmouseneuroscienceretinal ganglion cellretinogeniculatesynaptogenesisthalamus

Identifiers

PMID29424692
PMCPMC5826289
OpenAlexW2779370909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.